Daniella Beckman, Chief Financial Officer at Tango Therapeutics, Inc. (TNGX), sold 8,232 shares at $3.16 ($25K) on 2025-02-05, disclosed to the SEC on 2025-02-06.
Open-market sale of $25k TNGX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.99 | 4,284 | $13K | 50.7% |
| 2 | $3.16 | 3,948 | $12K | 49.3% |
| Total | $3.07 avg | 8,232 | $25K | 100% |
| Filing → |